Bronchodilator Reversibility of Spirometry and Oscillometry Ratios in Severe Refractory Asthma
Clinical & Experimental Allergy · 2026-01 · 56 (1) · 92-94
DOI: 10.1111/cea.70135 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical & Experimental Allergy, online erschienen am 10.08.2025. Verfasst von Robert Greig und 3 weiteren Autor:innen. Beteiligte Einrichtung: Scottish Centre for Respiratory Research, Ninewells Hospital and Medical School, Dundee, Scotland, UK. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AstraZeneca, Sanofi.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Scottish Centre for Respiratory Research, Ninewells Hospital and Medical School, Dundee, Scotland, UK.
ORCID-Profile: Robert Greig, Brian Lipworth
Förderung
- AstraZeneca
- Sanofi
Zitieren
APA
Greig, R., Suter, P., Chan, R., & Lipworth, B. (2026). Bronchodilator Reversibility of Spirometry and Oscillometry Ratios in Severe Refractory Asthma. Clinical & Experimental Allergy, 56(1), 92-94. https://doi.org/10.1111/cea.70135
Vancouver
Greig R, Suter P, Chan R, Lipworth B. Bronchodilator Reversibility of Spirometry and Oscillometry Ratios in Severe Refractory Asthma. Clinical & Experimental Allergy. 2026;56(1):92-94. doi:10.1111/cea.70135
BibTeX
@article{Greig2026,
author = {Greig, Robert and Suter, Philipp and Chan, Rory and Lipworth, Brian},
title = {Bronchodilator Reversibility of Spirometry and Oscillometry Ratios in Severe Refractory Asthma},
journal = {Clinical & Experimental Allergy},
year = {2026},
volume = {56},
number = {1},
pages = {92--94},
doi = {10.1111/cea.70135}
}
EUVIMED